Touchstone International Medical Science Co., Ltd. (SHA:688013)
59.46
-1.83 (-2.99%)
Oct 10, 2025, 3:00 PM CST
SHA:688013 Revenue
Touchstone International Medical Science had revenue of 90.32M CNY in the quarter ending June 30, 2025, with 24.56% growth. This brings the company's revenue in the last twelve months to 295.80M, up 14.26% year-over-year. In the year 2024, Touchstone International Medical Science had annual revenue of 272.37M with 7.38% growth.
Revenue (ttm)
295.80M
Revenue Growth
+14.26%
P/S Ratio
16.06
Revenue / Employee
1.12M
Employees
254
Market Cap
4.75B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 272.37M | 18.72M | 7.38% |
Dec 31, 2023 | 253.65M | 21.61M | 9.31% |
Dec 31, 2022 | 232.03M | 18.30M | 8.56% |
Dec 31, 2021 | 213.74M | 50.39M | 30.85% |
Dec 31, 2020 | 163.34M | -9.41M | -5.45% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 30.15B |
WuXi AppTec | 41.90B |
Shenzhen Mindray Bio-Medical Electronics | 32.94B |
Sichuan Biokin Pharmaceutical | 441.19M |
Shanghai United Imaging Healthcare | 10.98B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.52B |
Aier Eye Hospital Group | 21.94B |
Yunnan Baiyao Group Co.,Ltd | 40.84B |